(Q46675019)

24 December 2017

title

Activated nuclear factor-kappa B and cytokine profiles in the esophagus parallel tumor regression following neoadjuvant chemoradiotherapy (English)

1 reference

24 December 2017

0 references

5

1 reference

24 December 2017

author name string

M M M Abdel-Latif

1

1 reference

24 December 2017

J M O'Riordan

2

1 reference

24 December 2017

N Ravi

3

1 reference

24 December 2017

D Kelleher

4

1 reference

24 December 2017

publication date

1 January 2005

1 reference

24 December 2017

Diseases of the Esophagus

published in

1 reference

24 December 2017

volume

18

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

246-252

1 reference

24 December 2017

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Function and activation of NF-kappa B in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Nuclear factor-kappa B is upregulated in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Inhibition of inducible NF-kappaB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

The role of nuclear factor-kappa B in cytokine gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

The Vienna classification of gastrointestinal epithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Downstaging of esophageal cancer after preoperative radiation and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Ionizing radiation induces expression and binding activity of the nuclear factor kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

NF-kappaB activation plays an antiapoptotic role in human leukemic K562 cells exposed to ionizing radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

NF-kappa B signaling pathway as a target for human tumor radiosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2050.2005.00497.X

10.1111/J.1442-2050.2005.00497.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16128781

1 reference

24 December 2017